Berkeley Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,752	Closed	-$308K	–	162
2021 Q4	$308K	Sell	2,752 -22	-0.8%	-$2.65K	0.13%	109
2021 Q3	$349K	Sell	2,774 -12	-0.4%	-$1.54K	0.16%	91
2021 Q2	$377K	Sell	2,786 -77	-3%	-$10.1K	0.17%	86
2021 Q1	$388K	Buy	2,863 +13	+0.5%	+$1.95K	0.19%	78
2020 Q4	$401K	Sell	2,850 -151	-5%	-$19.3K	0.21%	72
2020 Q3	$334K	Buy	3,001 +108	+4%	+$12.1K	0.2%	71
2020 Q2	$324K	Buy	+2,893	New	+$285K	0.2%	78
2020 Q1	–	Sell	-2,918	Closed	-$278K	–	139
2019 Q4	$278K	Buy	+2,918	New	+$252K	0.14%	114
2019 Q3	–	Sell	-3,032	Closed	-$266K	–	135
2019 Q2	$266K	Buy	3,032 +92	+3%	+$7.85K	0.12%	120
2019 Q1	$266K	Buy	+2,940	New	+$250K	0.13%	117
2018 Q3	–	Sell	-2,678	Closed	-$254K	–	123
2018 Q2	$254K	Buy	+2,678	New	+$246K	0.15%	108
2016 Q1	–	Sell	-4,308	Closed	-$302K	–	124
2015 Q4	$302K	Buy	+4,308	New	+$294K	0.25%	79